Wang Jianli, Chen Li. Expression of p53, PCNA and Stroma Macrophage in Relation to the Degree of Differentiation in Squamous Cell Carcinoma of the Skin[J].Chinese Journal of Dermatology, 1997, 30(4): 253-255.
[1] Hall PA. Levison Da. Assessment of cell proliferation in histological material. J Clin Pathol, 1990,43:184.
[2] Galand P, DeGreef C. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissue. Cell Tiss Kinet, 1989,22:383.
[3] 陈莉, 肖玉凤, 陈岗.胃癌间质巨噬细胞和肥大细胞.中国肿瘤临床, 1994,21:281.
[4] Sano T, Taugino T, Yoshida K, et al. Frequent loss of heterozygosity on chromosomes 1q. 5q, and 19q in human gastric carcinoma. Cancer Res, 1996,51:2925.
[5] Bartek J, Bartekova J, Vojtesek B. et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene, 1991,6:1699.
[6] Choi SW, Hytiroglou P, Geller SA, et al. The expression of p53 antigen in primary malignant epithelial tumours of the liveran immunohistochemical study. Liver, 1993,131173.
[7] Eccles SA. Macrophage content of tumous in relation to metastatic spread and host immune reaction. Nature. 1974, 250:667.